Table 1.

Phenotype of NK Cells From G-CSF–Mobilized PBPCs Versus Unprimed PBMNCs

PhenotypeG-CSF PBPC NK CellsUnprimed PBMNC NK CellsP
CD56+/CD2+ 72 ± 4.6 (7) 58 ± 5.8 (6) NS 
CD56+/CD7+ 94 ± 1.9 (7) 98 ± 0.9 (6) NS 
CD56+/CD8+ 32 ± 6.2 (7) 32 ± 6.3 (6) NS 
CD56+/CD16+ 84 ± 2.5 (7) 86 ± 4.1 (6) NS 
CD56+ bright  6.3 ± 1.44 (9)  5.7 ± 0.8 (20) NS 
CD56+ bright MCF 146 ± 16 (9) 234 ± 15.5 (20) .002 
All CD56+ MCF 44 ± 5.0 (9) 63 ± 4.6 (20) .018 
PhenotypeG-CSF PBPC NK CellsUnprimed PBMNC NK CellsP
CD56+/CD2+ 72 ± 4.6 (7) 58 ± 5.8 (6) NS 
CD56+/CD7+ 94 ± 1.9 (7) 98 ± 0.9 (6) NS 
CD56+/CD8+ 32 ± 6.2 (7) 32 ± 6.3 (6) NS 
CD56+/CD16+ 84 ± 2.5 (7) 86 ± 4.1 (6) NS 
CD56+ bright  6.3 ± 1.44 (9)  5.7 ± 0.8 (20) NS 
CD56+ bright MCF 146 ± 16 (9) 234 ± 15.5 (20) .002 
All CD56+ MCF 44 ± 5.0 (9) 63 ± 4.6 (20) .018 

Data are presented as the percent of NK cells positive for each phenotype. The number in parentheses is the number of experiments.

Abbreviations: MCF, mean channel fluorescence; NS, not significant.

or Create an Account

Close Modal
Close Modal